Peter P. Ruvolo

The University of Texas MD Anderson Cancer Center — United States

Medicine · Health Sciences

43h-index8.5kcitations226works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(74), Protein Degradation and Inhibitors(38), Chronic Myeloid Leukemia Treatments(29), Cell death mechanisms and regulation(28), RNA modifications and cancer(20)

Publications226 total

Retraction Note: MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complex
Leukemia·2024Open Access
Supplementary Figure Legends from Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
2023Open Access
Supplementary Table 1 from Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
2023Open Access
Supplementary Methods from Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
2023Open Access
Supplementary Table 1 from Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
2023Open Access
Supplementary Data from Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization
2023Open Access
Supplementary Data from Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization
2023Open Access
Data from Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization
2023Open Access
Perspective on this Article from Chemopreventive Effect of Kava on 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone plus Benzo[<i>a</i>]pyrene–Induced Lung Tumorigenesis in A/J Mice
2023Open Access
Supplementary Figures from Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
2023Open Access
Supplementary Table 2 from Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
2023Open Access
Data from Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
2023Open Access
Perspective on this Article from Chemopreventive Effect of Kava on 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone plus Benzo[<i>a</i>]pyrene–Induced Lung Tumorigenesis in A/J Mice
2023Open Access
Supplementary Data from Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization
2023Open Access
Data from Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
2023Open Access
Data from Chemopreventive Effect of Kava on 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone plus Benzo[<i>a</i>]pyrene–Induced Lung Tumorigenesis in A/J Mice
2023Open Access
Data from Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization
2023Open Access
Supplementary Table 2 from Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure Legends from Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
2023Open Access
Supplementary Figures from Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
2023Open Access
page 1 of 12Next →

Frequent Co-authors

Michael Andreeff(24), Marina Konopleva(18), Vivian Ruvolo(14), Steven M. Kornblau(12), W. Stratford May(11), Xingming Deng(8), Hagop M. Kantarjian(8), Gautam Borthakur(7), Svitlana Kurinna(7), Teresa McQueen(5), Tilahun Jiffar(5), James A. McCubrey(5), Rooha Contractor(4), Zeev Estrov(4), Jörge E. Cortes(4), Hong Mu(4), R. Eric Davis(4), Numsen Hail(4), Twee Tsao(3), Wendy Schober(3)